Pre-Congress European Pancreatic Club EPC-2022 Course

Gut microbiome in pathogenesis and therapy of pancreatic, liver and GI tract diseases

Register Closed

ACCME Credits

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedExpert and LLC STARFISH-KF certified for CME credit. MedExpert is accredited by the ACCME to provide continuing medical education for physicians.

MedExpert designates this activity for a maximum of 7 AMA PRA Category 1 Credit [TM – as superscript]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Preliminary program

Section 1:  Potential pathogenic links of gut microbiome and pancreatic pathology

• Gut microflora in pancreatic diseases: possible pathogenic  mechanisms and risks – Albrecht Neesse (Germany)
• Alpha-1 antitrypsin deficiency: pancreatic-pulmonary – gut axes – Joanna Chorostowska (Poland)
• The microbiota and immune system crosstalk in pancreatic diseases – Gianluca Ianiro  (Italy)
• Syndrome of increased epithelial permeability in pancreatic pathology – Marco Romano (Italy)

Section 2: Gut microbiome changes in pancreatic diseases

• Role of gut microbiota on intestinal barrier function in acute pancreatitis – I.V. Khomiak (Ukraine)
• The gut microbiome in patients with chronic pancreatitis – Markus Lerch (Germany)
• Exocrine pancreatic insufficiency association with changes in intestinal microbiota composition – Dan Dumitrascu (Romania)
• Gut microbiota: its potential roles in pancreatic cancer – Cindy Neuzillet (France)

Section 3: Microbiome and liver diseases

• Morphological association of liver pathology with changes in the intestinal microbiome –  O.O. Dyadyk (Ukraine), Olga Wise (UK), Mark Howard (UK)
• The role of gut microbiome in non-alcoholic fatty liver disease – Fabian Frost (Germany)
• Microbiome and autoimmune liver diseases – Marcis Leja (Latvia)
• Gut microbiota in liver cirrhosis and its complications A.V. Nersesov, J.A. Kaibullayeva (Kazakhstan)

Section 4: Bowel diseases in pancreatic pathology and therapeutic potential of microbial modulation in pancreatic diseases

• Irritable bowel syndrome and exocrine pancreatic insufficiency – Tarkan Karakan (Turkey)
• IBD and chronic pancreatitis: extraintestinal manifestations or concomitant disease -A.E.Dorofeyev (Ukraine)
• Questions about the use of antibiotics in pancreatic disorders – G.G. Babayeva (Azerbaijan)
• Fecal microbiota transplantation in chronic pancreatitis treatment – S. M.Tkach (Ukraine)